Page 5 - 1701281_Value_Plus_NOV_2017
P. 5
Cadila Healthcare Ltd BUY TECHNICAL
CMP: Rs 496 (As on 03rd Nov 2017)
Buy: Rs 496-475 PICK
Target Price: Rs 535-550
Stop-Loss: Rs 460 Cadila Healthcare Ltd is one of the largest privately
Cadila held pharmaceutical companies in India. It operates
in areas of active pharmaceutical ingredients
5 ARIHANT CAPITAL ยก novembER 2017 (API) to formulations, and animal health products
to cosmeceuticals. It has been developing and
manufacturing pharmaceutical products and
selling and distributing these in over 50 countries
around the world. It caters to over 45 therapeutic
areas that include cardiovascular, gastrointestinal,
analgesics, haematinics, anti-infectives and
antibiotics, respiratory agents, antidiabetics and
immunologicals. The company focuses on providing
high quality, appropriately priced products to its
customers and supports all these with dedicated
customer service. It has a multicultural, multilingual
and multinational workforce of more than 4,000
employees including over 200 people outside India
in 49 countries of Africa, CIS, Japan and USA. The
Company's subsidiaries include Zydus Wellness
Limited, Liva Pharmaceuticals Ltd, Biochem
Pharmaceutical Industries Ltd, Zydus Technologies
Ltd, German Remedies Ltd, Dialforhealth India
Ltd, Dialforhealth Unity Ltd and Dialforhealth
Greencross Ltd.
Technical Outlook:
On the daily chart, the stock has given downward
sloping trendline breakout. Further the RSI is
positively poised hence momentum on the upside is
likely to continue.
Hence we recommend buying in stock at Rs 496 or
on a decline up to Rs 475 with a stop loss of Rs 460
for a target of Rs 535-550 levels.
